Quality Care
Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
Rx Savings Finder allows Walgreens' pharmacy customers to access low-cost prescriptions by comparing the price of medications on third-party discount cards.
Wearable sensors provide physiological biomarkers, helping to determine reasons for an athlete's performance and the necessity of altering training to avoid injury.
The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
The medtech company announced 40 innovations at RSNA23 aimed at streamlining the provider and patient healthcare experience.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
A study published in the New England Journal of Medicine says GPT-4 correctly diagnosed 52.7% of complex cases compared to only 36% of medical journal readers.
The company's product, Distill, uses machine learning algorithms and LLMs to perform administrative, clinical and research tasks that require chart review.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.